A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

NCT04086121 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Dermatitis, Atopic

Interventions

DRUG: Spesolimab

Sponsor

Boehringer Ingelheim